Stroke, Acute Clinical Trial
Official title:
Transcranial Direct Current Stimulation ASsociated With Physical-therapy In Acute Stroke Patients - the tDCS ASAP - a Randomized, Triple Blind, Sham-controlled Study ?
Acute stroke patient will undergo one month (20 sessions) of physical therapy and anodal
tDCS.
Patients will undergo functional outcomes measured at 48h post onset, 7,14,21,28 days, 3 and
6 months and one year post onset.
Recruitment :
Patients with acute stroke (24-48h after stroke) who have upper and / or lower sensorimotor
deficits
• Treatment : After being selected according to the inclusion and exclusion criteria of this
study, patients will be randomized and placed in one of two groups: placebo (P) or
transcranial anodic stimulation (A).
Once placed in one of two groups, patients will all receive intensive physiotherapy for
functional improvement in order to increase motor, postural and motor control. This
physiotherapy will be established 5 times a week (Monday to Friday).
In addition to physiotherapy, the patient will have electrodes placed on his head, attached
via a system of straps, to deliver either a continuous current (A) or no current (P) and at a
rate of 5 times per week for 4 weeks. Neither the physiotherapist nor the patient will know
what treatment he will have received.
• Evaluations and measurements:
Patients will be required to perform functional tests of the upper limb (Wolf Motor Function
Test (WMFT)), filmed and timed, a test of spasticity (Tardieu) as well as to answer certain
questionnaires concerning their perception of the evolution of the disease and their
disability (Stroke Impact Scale, Barthel Index), their emotional state (HADS), if they have
experienced side effects, sensitivity test with monofilaments or Semmes and Weinstein test,
the Fugl Meyer, the timed up and go, the test of 10m, the four step square test, the berg
balance scale, the postural assessment scale and the trunk impairment scale. These
evaluations will take place at Day 0 (corresponding to the first day after the 48h of strict
bedtime), Day 7, 15, 30, 90, 6 months and 1 year. They will be done in two stages, on two
successive days, so as not to exhaust the patient.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05378035 -
DOAC in Chinese Patients With Atrial Fibrillation
|
||
Completed |
NCT03679637 -
Tablet-based Aphasia Therapy in the Acute Phase After Stroke
|
N/A | |
Completed |
NCT03574038 -
Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke
|
N/A | |
Completed |
NCT03633422 -
Evaluation of Stroke Patient Screening
|
||
Completed |
NCT04088578 -
VNS-supplemented Motor Retraining After Stroke
|
N/A | |
Withdrawn |
NCT04991038 -
Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients
|
N/A | |
Not yet recruiting |
NCT05534360 -
Tenecteplase Treatment in Ischemic Stroke Registry
|
||
Withdrawn |
NCT05786170 -
ERILs Und SNILs Unter SOC
|
N/A | |
Not yet recruiting |
NCT04105322 -
Effects of Kinesio Taping on Balance and Functional Performance in Stroke Patients
|
N/A | |
Recruiting |
NCT03132558 -
Contrast Induced Acute Kidney in Patients With Acute Stroke
|
N/A | |
Completed |
NCT02893631 -
Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke
|
||
Active, not recruiting |
NCT02274727 -
Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
|
||
Completed |
NCT02225730 -
Imaging Collaterals in Acute Stroke (iCAS)
|
||
Terminated |
NCT01705353 -
The Role of HMGB-1 in Chronic Stroke
|
N/A | |
Active, not recruiting |
NCT01581502 -
SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)
|
N/A | |
Completed |
NCT01182818 -
Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease
|
N/A | |
Completed |
NCT00761982 -
Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.
|
Phase 1/Phase 2 | |
Completed |
NCT00535197 -
Autologous Bone Marrow Stem Cells in Ischemic Stroke.
|
Phase 1/Phase 2 | |
Terminated |
NCT00132509 -
FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic Stroke
|
Phase 2 | |
Recruiting |
NCT05760326 -
Diagnostic and Prognostic Role of Clot Analysis in Stroke Patients
|